US allows use of Remdesivir to treat COVID-19 patients

The Food and Drug Administration gave emergency use authorisation for the use of investigational anti-viral Remdesivir in the treatment of COVID-19 patients. Remdesivir has shown to have great promise in the lab and in animal models and for the first time now in human clinical trials.